Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-25-025470
Filing Date
2025-08-07
Accepted
2025-08-07 16:41:09
Documents
82
Period of Report
2025-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q pbyi20250630_10q.htm   iXBRL 10-Q 1527148
2 EXHIBIT 10.1 ex_849252.htm EX-10.1 76321
3 EXHIBIT 10.2 ex_848952.htm EX-10.2 79453
4 EXHIBIT 31.1 ex_831929.htm EX-31.1 8380
5 EXHIBIT 31.2 ex_831930.htm EX-31.2 8424
6 EXHIBIT 32.1 ex_831931.htm EX-32.1 5177
7 EXHIBIT 32.2 ex_831932.htm EX-32.2 5168
  Complete submission text file 0001437749-25-025470.txt   8253604

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION SCHEMA pbyi-20250630.xsd EX-101.SCH 67019
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE pbyi-20250630_cal.xml EX-101.CAL 61987
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE pbyi-20250630_def.xml EX-101.DEF 436398
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE pbyi-20250630_lab.xml EX-101.LAB 408821
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE pbyi-20250630_pre.xml EX-101.PRE 473392
85 EXTRACTED XBRL INSTANCE DOCUMENT pbyi20250630_10q_htm.xml XML 1460298
Mailing Address 10880 WILSHIRE BLVD. SUITE 2150 LOS ANGELES CA 90024
Business Address 10880 WILSHIRE BLVD. SUITE 2150 LOS ANGELES CA 90024 (424) 248-6500
PUMA BIOTECHNOLOGY, INC. (Filer) CIK: 0001401667 (see all company filings)

EIN.: 770683487 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35703 | Film No.: 251194879
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)